NCT01125813 - Efficacy and Safety Study of Human-cl rhFVIII in PTPs With Severe Hemophilia A | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Severe Hemophilia A

Interventions

BIOLOGICAL

recombinant Factor VIII

intravenous infusion of factor FVIII every other day.

Trial Locations (11)

Medizinische Universitaet Wien, Vienna

Haematological Hospital Joan Pavel, Sofia

Universitaetsklinikum Hamburg-Eppendorf, Hamburg

Werlhof Institut fuer Haemostaseologie GmbH, Hanover

SRH Kurpfalzkrankenhaus Heidelberg, Heidelberg

Universitaetsklinikum, Bonn

University Hospital of Wales, Cardiff

Royal Free Hospital, London

Manchester Royal Infirmary, Manchester

Royal Hallamshire Hospital, Sheffield

Basingstoke & North Hampshire NHS Foundation Trust, Basingstoke